Audrey Hendricks
Concepts (423)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Variation | 12 | 2026 | 972 | 2.550 |
Why?
| | Genome-Wide Association Study | 13 | 2026 | 1407 | 2.120 |
Why?
| | Software | 4 | 2026 | 680 | 2.000 |
Why?
| | Gene Frequency | 8 | 2026 | 487 | 1.500 |
Why?
| | Models, Genetic | 7 | 2025 | 524 | 1.490 |
Why?
| | Dog Diseases | 5 | 2024 | 86 | 1.430 |
Why?
| | Computer Simulation | 8 | 2026 | 1003 | 1.100 |
Why?
| | Haplotypes | 4 | 2026 | 499 | 1.090 |
Why?
| | Polymorphism, Single Nucleotide | 12 | 2026 | 2158 | 1.090 |
Why?
| | Genetic Association Studies | 3 | 2017 | 369 | 0.970 |
Why?
| | Pedigree | 3 | 2021 | 515 | 0.840 |
Why?
| | Exome | 4 | 2022 | 227 | 0.830 |
Why?
| | Models, Statistical | 3 | 2025 | 671 | 0.740 |
Why?
| | Infant Nutritional Physiological Phenomena | 5 | 2026 | 159 | 0.710 |
Why?
| | Data Interpretation, Statistical | 2 | 2021 | 368 | 0.680 |
Why?
| | Open Access Publishing | 1 | 2020 | 6 | 0.660 |
Why?
| | Genetic Predisposition to Disease | 10 | 2026 | 2378 | 0.660 |
Why?
| | Journal Impact Factor | 1 | 2020 | 29 | 0.650 |
Why?
| | Mite Infestations | 1 | 2020 | 9 | 0.620 |
Why?
| | Metagenomics | 1 | 2021 | 149 | 0.620 |
Why?
| | Minichromosome Maintenance Complex Component 6 | 1 | 2019 | 1 | 0.600 |
Why?
| | Huntington Disease | 5 | 2012 | 61 | 0.590 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 33 | 0.590 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 42 | 0.580 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 530 | 0.580 |
Why?
| | Diet | 6 | 2026 | 1277 | 0.560 |
Why?
| | Lymphoma | 1 | 2020 | 237 | 0.550 |
Why?
| | Periodicals as Topic | 1 | 2020 | 209 | 0.540 |
Why?
| | Obesity, Morbid | 2 | 2019 | 293 | 0.490 |
Why?
| | Dogs | 7 | 2024 | 458 | 0.480 |
Why?
| | Inheritance Patterns | 2 | 2021 | 45 | 0.470 |
Why?
| | Colorectal Neoplasms | 2 | 2026 | 866 | 0.460 |
Why?
| | Research Design | 1 | 2022 | 1137 | 0.460 |
Why?
| | Dairy Products | 3 | 2021 | 30 | 0.440 |
Why?
| | Meat | 3 | 2021 | 64 | 0.420 |
Why?
| | Toll-Like Receptors | 2 | 2012 | 193 | 0.400 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 27 | 0.400 |
Why?
| | Pediatric Obesity | 2 | 2020 | 638 | 0.390 |
Why?
| | Humans | 61 | 2026 | 145474 | 0.390 |
Why?
| | Penetrance | 2 | 2009 | 30 | 0.370 |
Why?
| | Genes | 1 | 2012 | 227 | 0.360 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1321 | 0.350 |
Why?
| | United Kingdom | 4 | 2020 | 344 | 0.340 |
Why?
| | Genome, Human | 4 | 2021 | 420 | 0.340 |
Why?
| | Alleles | 7 | 2023 | 894 | 0.330 |
Why?
| | Trinucleotide Repeat Expansion | 3 | 2009 | 43 | 0.330 |
Why?
| | Cyclosporine | 1 | 2012 | 256 | 0.330 |
Why?
| | Keratinocytes | 1 | 2012 | 249 | 0.320 |
Why?
| | Linkage Disequilibrium | 2 | 2026 | 253 | 0.310 |
Why?
| | Heterozygote | 2 | 2019 | 313 | 0.310 |
Why?
| | Obesity | 9 | 2025 | 3116 | 0.310 |
Why?
| | Case-Control Studies | 3 | 2026 | 3623 | 0.290 |
Why?
| | Body Mass Index | 4 | 2025 | 2445 | 0.290 |
Why?
| | Robotic Surgical Procedures | 2 | 2025 | 185 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 25 | 0.270 |
Why?
| | Animals | 21 | 2025 | 38030 | 0.270 |
Why?
| | Infant Formula | 2 | 2018 | 71 | 0.270 |
Why?
| | Child Development | 2 | 2026 | 483 | 0.260 |
Why?
| | Computational Biology | 1 | 2012 | 669 | 0.260 |
Why?
| | Stem Cells | 1 | 2012 | 628 | 0.260 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 838 | 0.250 |
Why?
| | Linear Models | 2 | 2022 | 845 | 0.250 |
Why?
| | Fast Foods | 1 | 2026 | 21 | 0.240 |
Why?
| | Dietary Sugars | 1 | 2026 | 21 | 0.240 |
Why?
| | Male | 42 | 2026 | 72842 | 0.240 |
Why?
| | Sodium, Dietary | 1 | 2026 | 42 | 0.240 |
Why?
| | Anastomotic Leak | 1 | 2026 | 45 | 0.240 |
Why?
| | Weaning | 1 | 2026 | 51 | 0.240 |
Why?
| | Female | 42 | 2026 | 78844 | 0.240 |
Why?
| | Genotype | 6 | 2023 | 1852 | 0.230 |
Why?
| | Infant Food | 1 | 2026 | 69 | 0.230 |
Why?
| | Energy Intake | 4 | 2026 | 512 | 0.230 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2025 | 32 | 0.230 |
Why?
| | Thyroid Diseases | 1 | 2026 | 44 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.220 |
Why?
| | Genetics, Population | 2 | 2025 | 217 | 0.220 |
Why?
| | Adrenalectomy | 1 | 2025 | 68 | 0.220 |
Why?
| | Perinatal Care | 1 | 2025 | 59 | 0.220 |
Why?
| | Otitis Externa | 1 | 2024 | 3 | 0.220 |
Why?
| | Tamoxifen | 1 | 2025 | 191 | 0.220 |
Why?
| | Algorithms | 2 | 2026 | 1845 | 0.210 |
Why?
| | Prevalence | 3 | 2024 | 2865 | 0.210 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2187 | 0.210 |
Why?
| | Learning Curve | 1 | 2025 | 71 | 0.210 |
Why?
| | Middle Aged | 24 | 2026 | 36215 | 0.210 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2025 | 193 | 0.210 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2025 | 98 | 0.200 |
Why?
| | Colonic Neoplasms | 1 | 2026 | 257 | 0.200 |
Why?
| | Hypothalamus | 3 | 2019 | 163 | 0.200 |
Why?
| | Energy Metabolism | 3 | 2019 | 935 | 0.190 |
Why?
| | HLA-DP beta-Chains | 1 | 2023 | 88 | 0.190 |
Why?
| | Dysbiosis | 1 | 2024 | 187 | 0.190 |
Why?
| | Lactation | 1 | 2024 | 193 | 0.190 |
Why?
| | Anthropometry | 3 | 2018 | 206 | 0.190 |
Why?
| | Parkinson Disease | 4 | 2011 | 599 | 0.180 |
Why?
| | Dietary Supplements | 2 | 2024 | 583 | 0.180 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 178 | 0.180 |
Why?
| | Micronutrients | 2 | 2026 | 102 | 0.180 |
Why?
| | Thyroid Neoplasms | 1 | 2026 | 350 | 0.170 |
Why?
| | Aged | 18 | 2026 | 26153 | 0.170 |
Why?
| | Iodine | 1 | 2021 | 27 | 0.170 |
Why?
| | Zinc | 1 | 2024 | 306 | 0.160 |
Why?
| | Alopecia | 1 | 2020 | 37 | 0.160 |
Why?
| | Quantitative Trait Loci | 3 | 2019 | 378 | 0.160 |
Why?
| | Hair Follicle | 1 | 2020 | 49 | 0.160 |
Why?
| | Multifactorial Inheritance | 1 | 2022 | 195 | 0.160 |
Why?
| | Pro-Opiomelanocortin | 1 | 2020 | 20 | 0.160 |
Why?
| | Health Benefit Plans, Employee | 3 | 2000 | 25 | 0.160 |
Why?
| | Laparoscopy | 1 | 2025 | 481 | 0.160 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 184 | 0.160 |
Why?
| | Mice | 9 | 2022 | 18329 | 0.160 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.150 |
Why?
| | Muscle Proteins | 2 | 2019 | 242 | 0.150 |
Why?
| | Receptors, Cell Surface | 2 | 2019 | 372 | 0.150 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 777 | 0.150 |
Why?
| | Breeding | 1 | 2019 | 63 | 0.150 |
Why?
| | Risk Factors | 5 | 2026 | 10885 | 0.150 |
Why?
| | Nuclear Receptor Coactivator 1 | 1 | 2019 | 5 | 0.150 |
Why?
| | Melanocortins | 1 | 2019 | 1 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 112 | 0.140 |
Why?
| | Food | 1 | 2020 | 150 | 0.140 |
Why?
| | Telomere Shortening | 1 | 2018 | 19 | 0.140 |
Why?
| | Poisson Distribution | 1 | 2018 | 78 | 0.140 |
Why?
| | Nerve Tissue Proteins | 3 | 2019 | 591 | 0.140 |
Why?
| | Longitudinal Studies | 2 | 2026 | 2953 | 0.140 |
Why?
| | Semaphorins | 1 | 2019 | 37 | 0.140 |
Why?
| | Thinness | 1 | 2019 | 100 | 0.140 |
Why?
| | Metabolomics | 2 | 2021 | 732 | 0.130 |
Why?
| | Adult | 19 | 2025 | 40777 | 0.130 |
Why?
| | Rectum | 1 | 2019 | 182 | 0.130 |
Why?
| | Chromogranins | 1 | 2017 | 13 | 0.130 |
Why?
| | GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 9 | 0.130 |
Why?
| | Stomach | 1 | 2017 | 111 | 0.130 |
Why?
| | Disease-Free Survival | 1 | 2019 | 767 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 456 | 0.130 |
Why?
| | Rodentia | 1 | 2017 | 61 | 0.130 |
Why?
| | Brain | 5 | 2019 | 2947 | 0.120 |
Why?
| | Consumer Behavior | 1 | 1997 | 69 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2017 | 62 | 0.120 |
Why?
| | Esophagectomy | 1 | 2017 | 135 | 0.120 |
Why?
| | Colon | 1 | 2019 | 309 | 0.120 |
Why?
| | Brain Neoplasms | 1 | 2026 | 1329 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2597 | 0.120 |
Why?
| | Population | 1 | 2016 | 30 | 0.120 |
Why?
| | Metabolome | 1 | 2020 | 388 | 0.120 |
Why?
| | Neurons | 4 | 2019 | 1649 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1374 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 441 | 0.110 |
Why?
| | Trinucleotide Repeats | 2 | 2012 | 31 | 0.110 |
Why?
| | Esophagus | 1 | 2017 | 262 | 0.110 |
Why?
| | Interleukin-8 | 2 | 2017 | 269 | 0.110 |
Why?
| | Health | 1 | 2015 | 82 | 0.110 |
Why?
| | Telomere | 1 | 2018 | 287 | 0.110 |
Why?
| | Prognosis | 2 | 2026 | 4316 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 507 | 0.110 |
Why?
| | Quality Assurance, Health Care | 1 | 1997 | 342 | 0.110 |
Why?
| | Disease | 1 | 2015 | 96 | 0.110 |
Why?
| | Iron | 1 | 2017 | 357 | 0.110 |
Why?
| | Models, Molecular | 2 | 2017 | 1598 | 0.110 |
Why?
| | Odds Ratio | 1 | 2017 | 1082 | 0.110 |
Why?
| | Mutation | 3 | 2017 | 4075 | 0.100 |
Why?
| | Protein Conformation | 1 | 2017 | 938 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1923 | 0.100 |
Why?
| | Dietary Proteins | 3 | 2020 | 135 | 0.100 |
Why?
| | Transcription Factors | 2 | 2019 | 1734 | 0.100 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 523 | 0.100 |
Why?
| | MicroRNAs | 1 | 2019 | 686 | 0.100 |
Why?
| | Infant | 6 | 2026 | 10077 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2382 | 0.090 |
Why?
| | Age of Onset | 5 | 2013 | 555 | 0.090 |
Why?
| | Genetic Testing | 2 | 2013 | 480 | 0.090 |
Why?
| | Neostriatum | 1 | 2012 | 37 | 0.090 |
Why?
| | Codon, Terminator | 1 | 2012 | 25 | 0.090 |
Why?
| | Mutation Rate | 1 | 2012 | 33 | 0.090 |
Why?
| | Veterinary Medicine | 1 | 2012 | 11 | 0.090 |
Why?
| | Biomarkers | 5 | 2024 | 4295 | 0.090 |
Why?
| | Population Density | 1 | 2012 | 89 | 0.090 |
Why?
| | Genetic Linkage | 2 | 2011 | 272 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2507 | 0.090 |
Why?
| | Recombination, Genetic | 1 | 2012 | 203 | 0.080 |
Why?
| | Genetic Loci | 1 | 2012 | 264 | 0.080 |
Why?
| | Body Weight | 3 | 2019 | 971 | 0.080 |
Why?
| | Atrial Fibrillation | 1 | 2016 | 558 | 0.080 |
Why?
| | Cohort Studies | 6 | 2021 | 6013 | 0.080 |
Why?
| | Intestinal Diseases | 1 | 2010 | 43 | 0.080 |
Why?
| | Nutritional Status | 2 | 2024 | 353 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2020 | 4148 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 409 | 0.070 |
Why?
| | Databases, Genetic | 3 | 2017 | 238 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 767 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2026 | 17291 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2012 | 473 | 0.070 |
Why?
| | Gene Expression | 2 | 2017 | 1476 | 0.070 |
Why?
| | Multivariate Analysis | 4 | 2016 | 1547 | 0.070 |
Why?
| | ELAV Proteins | 1 | 2008 | 14 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2010 | 246 | 0.070 |
Why?
| | Genomic Instability | 1 | 2008 | 67 | 0.070 |
Why?
| | Serine | 1 | 2008 | 143 | 0.070 |
Why?
| | Glucocorticoids | 1 | 2012 | 531 | 0.070 |
Why?
| | Glycine | 1 | 2008 | 186 | 0.060 |
Why?
| | Leptin | 2 | 2019 | 248 | 0.060 |
Why?
| | tau Proteins | 1 | 2008 | 105 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1217 | 0.060 |
Why?
| | Pilot Projects | 3 | 2025 | 1891 | 0.060 |
Why?
| | DNA Methylation | 2 | 2025 | 674 | 0.060 |
Why?
| | Young Adult | 5 | 2024 | 14218 | 0.060 |
Why?
| | Syndrome | 2 | 2017 | 381 | 0.060 |
Why?
| | Nutritive Value | 1 | 2026 | 41 | 0.060 |
Why?
| | Pregnancy | 3 | 2025 | 7202 | 0.060 |
Why?
| | Diet Records | 1 | 2026 | 89 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2026 | 5423 | 0.060 |
Why?
| | DNA Repair | 1 | 2008 | 254 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2012 | 835 | 0.060 |
Why?
| | Zimbabwe | 1 | 2025 | 76 | 0.060 |
Why?
| | Aged, 80 and over | 6 | 2018 | 8333 | 0.060 |
Why?
| | CpG Islands | 1 | 2025 | 163 | 0.060 |
Why?
| | Species Specificity | 2 | 2020 | 546 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 33 | 0.060 |
Why?
| | Insulin Resistance | 1 | 2013 | 1244 | 0.050 |
Why?
| | Malassezia | 1 | 2024 | 5 | 0.050 |
Why?
| | Massachusetts | 2 | 2013 | 180 | 0.050 |
Why?
| | Homeostasis | 2 | 2019 | 642 | 0.050 |
Why?
| | Crosses, Genetic | 2 | 2019 | 123 | 0.050 |
Why?
| | Fluoroquinolones | 1 | 2024 | 44 | 0.050 |
Why?
| | Leukocytes | 2 | 2018 | 296 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2010 | 675 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2025 | 175 | 0.050 |
Why?
| | Phenotype | 3 | 2019 | 3155 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2012 | 2803 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4560 | 0.050 |
Why?
| | Preconception Care | 1 | 2024 | 50 | 0.050 |
Why?
| | India | 1 | 2024 | 213 | 0.050 |
Why?
| | Prenatal Care | 1 | 2025 | 309 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 377 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2012 | 1371 | 0.050 |
Why?
| | Biopsy | 2 | 2020 | 1082 | 0.050 |
Why?
| | Child, Preschool | 4 | 2021 | 11853 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 118 | 0.050 |
Why?
| | Meta-Analysis as Topic | 2 | 2017 | 171 | 0.050 |
Why?
| | Age Factors | 3 | 2018 | 3342 | 0.050 |
Why?
| | Weight Gain | 1 | 2026 | 561 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2017 | 2129 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 408 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 946 | 0.040 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.040 |
Why?
| | Tanzania | 1 | 2021 | 72 | 0.040 |
Why?
| | Isoleucine | 1 | 2021 | 15 | 0.040 |
Why?
| | Survival Rate | 1 | 2026 | 2090 | 0.040 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2021 | 39 | 0.040 |
Why?
| | United States | 5 | 2026 | 16098 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 679 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2024 | 6447 | 0.040 |
Why?
| | Child | 5 | 2021 | 22707 | 0.040 |
Why?
| | Hospitals, Veterans | 2 | 2000 | 258 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2021 | 139 | 0.040 |
Why?
| | Phenylalanine | 1 | 2021 | 69 | 0.040 |
Why?
| | Valine | 1 | 2021 | 83 | 0.040 |
Why?
| | Leucine | 1 | 2021 | 116 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 91 | 0.040 |
Why?
| | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 2 | 2011 | 11 | 0.040 |
Why?
| | Hair | 1 | 2020 | 84 | 0.040 |
Why?
| | Principal Component Analysis | 2 | 2011 | 193 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 62 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 83 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2019 | 2188 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 174 | 0.040 |
Why?
| | Health Services Accessibility | 2 | 2025 | 1101 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2019 | 61 | 0.040 |
Why?
| | Diagnostic Tests, Routine | 1 | 2000 | 107 | 0.040 |
Why?
| | Length of Stay | 1 | 2025 | 1349 | 0.040 |
Why?
| | DNA Mutational Analysis | 2 | 2011 | 407 | 0.040 |
Why?
| | Nelfinavir | 1 | 1998 | 8 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5983 | 0.030 |
Why?
| | Blood Urea Nitrogen | 1 | 2018 | 53 | 0.030 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 32 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2019 | 278 | 0.030 |
Why?
| | Sex Factors | 2 | 2018 | 2105 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2024 | 602 | 0.030 |
Why?
| | Milk | 1 | 2018 | 119 | 0.030 |
Why?
| | Fetal Development | 1 | 2021 | 298 | 0.030 |
Why?
| | HIV Protease Inhibitors | 1 | 1998 | 69 | 0.030 |
Why?
| | Conversion to Open Surgery | 1 | 2017 | 22 | 0.030 |
Why?
| | Proteins | 2 | 2017 | 1023 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 592 | 0.030 |
Why?
| | Proteobacteria | 1 | 2017 | 16 | 0.030 |
Why?
| | Polymorphism, Genetic | 2 | 2012 | 614 | 0.030 |
Why?
| | Bifidobacterium | 1 | 2017 | 21 | 0.030 |
Why?
| | Thorax | 1 | 2017 | 51 | 0.030 |
Why?
| | Clostridium | 1 | 2017 | 19 | 0.030 |
Why?
| | Neurosecretory Systems | 1 | 2017 | 31 | 0.030 |
Why?
| | Bayes Theorem | 1 | 2019 | 420 | 0.030 |
Why?
| | Gene Deletion | 1 | 2019 | 391 | 0.030 |
Why?
| | Physical Chromosome Mapping | 1 | 2017 | 21 | 0.030 |
Why?
| | Powders | 1 | 2017 | 44 | 0.030 |
Why?
| | Insurance, Health, Reimbursement | 1 | 1998 | 98 | 0.030 |
Why?
| | Diabetic Retinopathy | 1 | 2000 | 209 | 0.030 |
Why?
| | Lipodystrophy | 1 | 2017 | 12 | 0.030 |
Why?
| | Genes, Homeobox | 1 | 2017 | 50 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 608 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2000 | 336 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 335 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1747 | 0.030 |
Why?
| | Patient Positioning | 1 | 2017 | 70 | 0.030 |
Why?
| | Operative Time | 1 | 2017 | 181 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2017 | 162 | 0.030 |
Why?
| | Neoplasm, Residual | 1 | 2017 | 143 | 0.030 |
Why?
| | Kenya | 1 | 2017 | 129 | 0.030 |
Why?
| | Abdomen | 1 | 2017 | 142 | 0.030 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 38 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 741 | 0.030 |
Why?
| | Islands | 1 | 2016 | 3 | 0.030 |
Why?
| | Aftercare | 1 | 1998 | 222 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2016 | 63 | 0.030 |
Why?
| | Croatia | 1 | 2016 | 4 | 0.030 |
Why?
| | Drosophila | 1 | 2017 | 164 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 2017 | 157 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2017 | 506 | 0.030 |
Why?
| | Eating | 1 | 2019 | 387 | 0.030 |
Why?
| | Body Height | 1 | 2017 | 202 | 0.030 |
Why?
| | Autoantibodies | 1 | 2023 | 1509 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 147 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2018 | 317 | 0.030 |
Why?
| | Reproductive Isolation | 1 | 2016 | 44 | 0.030 |
Why?
| | Genetics, Medical | 1 | 2015 | 23 | 0.030 |
Why?
| | Receptors, LDL | 1 | 2015 | 53 | 0.030 |
Why?
| | Skin | 1 | 2020 | 753 | 0.030 |
Why?
| | Choice Behavior | 1 | 1997 | 180 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2016 | 154 | 0.030 |
Why?
| | Birth Weight | 1 | 2018 | 514 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 105 | 0.030 |
Why?
| | Reference Standards | 1 | 2015 | 177 | 0.030 |
Why?
| | Time Factors | 1 | 2026 | 7123 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 1997 | 280 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 749 | 0.030 |
Why?
| | Health Services Research | 1 | 1997 | 391 | 0.030 |
Why?
| | Zebrafish | 1 | 2019 | 532 | 0.030 |
Why?
| | Feces | 1 | 2017 | 495 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 1997 | 639 | 0.030 |
Why?
| | Base Sequence | 1 | 2017 | 2170 | 0.030 |
Why?
| | Pseudogenes | 1 | 2013 | 20 | 0.030 |
Why?
| | Hyperphagia | 1 | 2013 | 38 | 0.020 |
Why?
| | Adiponectin | 1 | 2015 | 241 | 0.020 |
Why?
| | Lipoprotein Lipase | 1 | 2013 | 56 | 0.020 |
Why?
| | Fatty Acid Desaturases | 1 | 2013 | 31 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2381 | 0.020 |
Why?
| | Cell Line | 1 | 2019 | 2823 | 0.020 |
Why?
| | Triglycerides | 1 | 2015 | 520 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 8057 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2013 | 362 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 22529 | 0.020 |
Why?
| | Escherichia coli | 1 | 2017 | 835 | 0.020 |
Why?
| | Blood Pressure | 1 | 2020 | 1779 | 0.020 |
Why?
| | Caudate Nucleus | 1 | 2012 | 22 | 0.020 |
Why?
| | Gliosis | 1 | 2012 | 30 | 0.020 |
Why?
| | Autopsy | 1 | 2012 | 94 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 910 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2017 | 2062 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2012 | 48 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2016 | 492 | 0.020 |
Why?
| | State Health Plans | 1 | 1992 | 28 | 0.020 |
Why?
| | Cat Diseases | 1 | 2012 | 27 | 0.020 |
Why?
| | England | 1 | 2012 | 108 | 0.020 |
Why?
| | HIV-1 | 1 | 1998 | 908 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 529 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 149 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 307 | 0.020 |
Why?
| | Cats | 1 | 2012 | 231 | 0.020 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2013 | 223 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2017 | 782 | 0.020 |
Why?
| | Organ Size | 1 | 2012 | 461 | 0.020 |
Why?
| | Cadaver | 1 | 2012 | 311 | 0.020 |
Why?
| | Patient Acceptance of Health Care | 1 | 1998 | 881 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2013 | 855 | 0.020 |
Why?
| | Medically Uninsured | 1 | 1992 | 132 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 500 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3542 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 1038 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 1998 | 912 | 0.020 |
Why?
| | Family Health | 1 | 2011 | 191 | 0.020 |
Why?
| | Fatty Acids | 1 | 2013 | 457 | 0.020 |
Why?
| | Genomics | 1 | 2015 | 825 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 1067 | 0.020 |
Why?
| | Anxiety | 1 | 2017 | 1118 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 11772 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 866 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2883 | 0.020 |
Why?
| | MutS Homolog 3 Protein | 1 | 2008 | 2 | 0.020 |
Why?
| | Huntingtin Protein | 1 | 2008 | 13 | 0.020 |
Why?
| | MutS Homolog 2 Protein | 1 | 2008 | 12 | 0.020 |
Why?
| | ELAV-Like Protein 4 | 1 | 2008 | 1 | 0.020 |
Why?
| | DNA Repeat Expansion | 1 | 2008 | 10 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 707 | 0.020 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2008 | 54 | 0.020 |
Why?
| | Glucose | 1 | 2013 | 1048 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 365 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1969 | 0.020 |
Why?
| | Corpus Striatum | 1 | 2008 | 179 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5904 | 0.020 |
Why?
| | Veterans | 1 | 1998 | 1635 | 0.010 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3413 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1716 | 0.010 |
Why?
| | Bacteria | 1 | 2010 | 765 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 1997 | 6066 | 0.010 |
Why?
| | Chronic Disease | 1 | 2010 | 1808 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 740 | 0.010 |
Why?
| | HIV Infections | 1 | 1998 | 3193 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2008 | 1480 | 0.010 |
Why?
| | Benchmarking | 1 | 2000 | 191 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1998 | 79 | 0.010 |
Why?
| | Private Sector | 1 | 1998 | 50 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 64 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 280 | 0.010 |
Why?
| | Health Care Surveys | 1 | 1998 | 536 | 0.010 |
Why?
| | RNA, Viral | 1 | 1998 | 692 | 0.010 |
Why?
| | Medicare | 1 | 2000 | 903 | 0.010 |
Why?
| | United States Department of Veterans Affairs | 1 | 1998 | 778 | 0.010 |
Why?
| | New York | 1 | 1992 | 128 | 0.010 |
Why?
| | Patient Discharge | 1 | 1998 | 992 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2000 | 2588 | 0.000 |
Why?
|
|
Hendricks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|